Imbruvica 420 MG tablet 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FJC0X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,869
Award facts
- Contract value 100% obligated
- $63,869.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $63,869.44 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count packages) under a firm fixed-price contract structure. This is a non-set-aside award issued on December 3, 2025, with an ultimate completion date of December 24, 2025. The contractor will perform delivery operations from its corporate office located in Conshohocken, Pennsylvania. This delivery order is issued against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and established federal healthcare solutions provider, has demonstrated substantial capability in supplying diverse pharmaceutical products and medical commodities to military and veteran healthcare systems through competitive procurement. IMBRUVICA is a prescription medication used primarily in oncology treatments, consistent with the company's portfolio of specialty pharmaceuticals supporting Defense Health Agency and other federal healthcare customers. The award reflects the contractor's position as a critical vendor within DLA's medical supply chain infrastructure, serving multiple regions and therapeutic domains through its prime vendor arrangement.
Quick answers
Who was awarded contract SPE2DR26FJC0X?
SPE2DR26FJC0X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FJC0X worth?
The government has obligated $63,869 on SPE2DR26FJC0X.
Is contract SPE2DR26FJC0X an order under another contract?
Yes. SPE2DR26FJC0X is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJC0X competed?
The extent of competition for SPE2DR26FJC0X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award